In silico Modeling and Toxicity Profiling of a Set of Quinoline Derivatives as c-MET Inhibitors in the treatment of Human Tumors (original) (raw)
A Novel Approach for the Virtual Screening and Rational Design of Anticancer Compounds
Alina Montero
Journal of Medicinal Chemistry, 2000
View PDFchevron_right
Computer-aided drug design and the biological evaluation of anti-cancer drugs
Razia Moorad
2016
View PDFchevron_right
A facile in silico drug design strategy based on reference listed drugs and computational modeling of novel anticancer therapeutics
Asha Thomas
Sanat Tasarim Dergisi
View PDFchevron_right
In silico modelling of quantitative structure–activity relationship of multi-target anticancer compounds on k-562 cell line
Stephen Abechi
Network Modeling Analysis in Health Informatics and Bioinformatics, 2018
View PDFchevron_right
Rational drug design of antineoplastic agents using 3D-QSAR, cheminformatic, and virtual screening approaches
Katarina Nikolic
Current medicinal chemistry, 2017
View PDFchevron_right
Computational Virtual Screening Towards Designing Novel Anticancer Drugs
柏源 陳
View PDFchevron_right
Prediction of anticancer molecules using hybrid model developed on molecules screened against NCI-60 cancer cell lines
harinder singh
BMC cancer, 2015
View PDFchevron_right
In silico- internet and analogue based drug design of new anticancer agent
Ajay Bisht
The Pharma Innovation Journal, 2016
View PDFchevron_right
Pharmacophore modeling and virtual screening studies for new VEGFR-2 kinase inhibitors
Kyungik Lee
European Journal of Medicinal Chemistry, 2010
View PDFchevron_right
Molecular Modelling Studies on Molecular Pathways Related to Tumorigenesis in the Discovery of New Lead Compounds
Licia Pantano
2012
View PDFchevron_right
Assessment of in Vitro and in Vivo Activities in the National Cancer Institute's Anticancer Screen with Respect to Chemical Structure, Target Specificity, and Mechanism of Action
Ruili Huang
Journal of Medicinal Chemistry, 2006
View PDFchevron_right
Contemporary pre-clinical development of anticancer agents – What are the optimal preclinical models?
Maurizio D'Incalci
European Journal of Cancer, 2009
View PDFchevron_right
Structure-activity relationship and in silico development of c-Met kinase inhibitors
Suparna Ghosh
View PDFchevron_right
Molecular modeling studies of quinoline derivatives as VEGFR-2 tyrosine kinase inhibitors using pharmacophore based 3D QSAR and docking approach
alireza azizi
View PDFchevron_right
Analogue-based approaches in anti-cancer compound modelling: the relevance of QSAR models
g narahari sastry
Organic and Medicinal Chemistry Letters, 2011
View PDFchevron_right
Application of Quantitative Structure-Activity Relationships in the Prediction of New Compounds with Anti-Leukemic Activity
Francisco Torrens
International Journal of Molecular Sciences
View PDFchevron_right
Structure-Based Development of Anticancer Drugs
Mario Bianchet
Structure, 2001
View PDFchevron_right
Activity and toxicity modelling of some NCI selected compounds against leukemia P388ADR cell line using genetic algorithm-multiple linear regressions
Stephen Abechi
Journal of King Saud University - Science, 2018
View PDFchevron_right
Synthesis, molecular modeling and anti-cancer evaluation of a series of quinazoline derivatives
Ahmed Khodair
Carbohydrate Research, 2019
View PDFchevron_right
Discovery of New Quinoxalines as Cytotoxic Agents: Design, Synthesis and Molecular Modeling
Yossry Ammar
Azhar International Journal of Pharmaceutical and Medical Sciences
View PDFchevron_right
Design Synthesis and Evaluation of Novel Anticancer Agents
Mahaveer Singh
2017
View PDFchevron_right
Pharmacophore modeling and virtual screening studies to design some potential histone deacetylase inhibitors as new leads
VADIVELAN G
Journal of Molecular Graphics & Modelling, 2008
View PDFchevron_right
Pharmacophore generation and atom-based 3D-QSAR of novel quinoline-3-carbonitrile derivatives as Tpl2 kinase inhibitors
venkata reddy gorla
Journal of Enzyme Inhibition and Medicinal Chemistry, 2011
View PDFchevron_right
Virtual screening strategies: Recent advances in the identification and design of anti-cancer agents
SHAGUN KRISHNA
View PDFchevron_right
Dual-Target Anticancer Drug Candidates: Rational Design and Simulation Studies
Delara Mohammad-Aghaie
Physical Chemistry Research, 2015
View PDFchevron_right
Application of Mathematical Modeling and Computational Tools in the Modern Drug Design and Development Process
Rifat Hasan
Molecules, 2022
View PDFchevron_right
Application of Computer Modeling to Drug Discovery: Case Study of PRK1 Kinase Inhibitors as Potential Drugs in Prostate Cancer Treatment
Fidele Ntie-Kang
Unique Aspects of Anti-cancer Drug Development
View PDFchevron_right
Editorial: Computational drug discovery of medicinal compounds for cancer management
Faez I Khan
Frontiers in Chemistry, 2023
View PDFchevron_right
The Development of New Molecules Having Antiemetic Activity Using Molecular Modeling
Yacine Benguerba
Current Research in Bioinformatics
View PDFchevron_right
Molecular modeling studies and synthesis of novel quinoxaline derivatives with potential anti-cancer activity as inhibitors of methionine synthase
Mohamed Hammad
Medicinal Chemistry Research, 2012
View PDFchevron_right
Virtual Screening and Synthesis of New Chemical Scaffolds as VEGFR-2 Kinase Inhibitors
mohamed elsayed
Arzneimittelforschung, 2012
View PDFchevron_right
Discovery of potential ALK inhibitors by virtual screening approach
Anish Kumar
3 Biotech, 2016
View PDFchevron_right
In Silico Elucidation of Some Quinoline Derivatives with Potent Anti-Breast Cancer Activities
momohjimoh idris ovaku
The Journal of Engineering and Exact Sciences
View PDFchevron_right
Virtual Screening and its Experimental Validation Reveal Novel Compounds with Promising Anticancer Activity Among 4-Thiazolidinone- Pyrazoline- and Isatin-Based Conjugates
Stanislav Avdieiev, Oleg Devinyak
View PDFchevron_right
Rational Drug Design for Identifying Novel Multi-target Inhibitors for Hepatocellular Carcinoma
M. Elhefnawi
View PDFchevron_right